Approval · Notice of Compliance 36312 · 2025
PROQUAD: Notice of Compliance 36312
Issued October 16, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36312
- Date
- October 16, 2025
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROQUAD | Not yet assigned | — |
Medicinal ingredients
- VARICELLA VIRUS LIVE ATTENUATED (OKA/MERCK STRAIN) 3.99 L10PFU per DOSE
- RUBELLA VIRUS LIVE ATTENUATED (WISTAR RA 27/3 STRAIN) 3 L10T50 per DOSE
- MUMPS VIRUS LIVE ATTENUATED (JERYL LYNN STRAIN) 4.3 L10T50 per DOSE
- MEASLES VIRUS LIVE ATTENUATED (EDMONSTON STRAIN) 3 L10T50 per DOSE